Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 489

1.

Symptoms Predictive of Acute Myocardial Infarction in the Troponin Era: Analysis From the TRAPID-AMI Study.

McCord J, Aurora L, Lindahl B, Giannitsis E, Calle-Muller C, Nowak R, Body R, Christ M, deFilippi CR, Christenson RH, Jacobsen G, Alquezar A, Panteghini M, Melki D, Plebani M, Verschuren F, French J, Bendig G, Weiser S, Mueller C; TRAPID-AMI Investigators.

Crit Pathw Cardiol. 2019 Mar;18(1):10-15. doi: 10.1097/HPC.0000000000000163.

PMID:
30747759
2.

Associations of microvascular dysfunction with cardiovascular outcomes: The cardiac, endothelial function and arterial stiffness in ESRD (CERES) cohort.

Ayer A, Mills C, Donovan C, Christenson RH, Ganz P, Dubin RF.

Hemodial Int. 2019 Feb 6. doi: 10.1111/hdi.12675. [Epub ahead of print]

PMID:
30724445
3.

Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes.

Ghorbani A, Bhambhani V, Christenson RH, Meijers WC, deBoer RA, Levy D, Larson MG, Ho JE.

J Am Coll Cardiol. 2018 Dec 25;72(25):3246-3254. doi: 10.1016/j.jacc.2018.09.076.

PMID:
30573026
4.

1-h Evaluation for Acute Myocardial Infarction Using the Generation 5 Cardiac Troponin T Assay.

Nowak RM, Gandolfo CM, Jacobsen G, Christenson RH, Moyer M, Hudson M, McCord J.

J Am Coll Cardiol. 2018 Nov 27;72(21):2677-2679. doi: 10.1016/j.jacc.2018.08.2190. No abstract available.

PMID:
30466528
5.

Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction.

Mueller-Hennessen M, Lindahl B, Giannitsis E, Vafaie M, Biener M, Haushofer AC, Seier J, Christ M, Alquézar-Arbé A, deFilippi CR, McCord J, Body R, Panteghini M, Jernberg T, Plebani M, Verschuren F, French JK, Christenson RH, Dinkel C, Katus HA, Mueller C.

Int J Cardiol. 2019 Feb 1;276:261-267. doi: 10.1016/j.ijcard.2018.10.084. Epub 2018 Oct 26.

PMID:
30404726
6.

Provocative biomarker stress test: stress-delta N-terminal pro-B type natriuretic peptide.

Limkakeng AT Jr, Leahy JC, Griffin SM, Lokhnygina Y, Jaffa E, Christenson RH, Newby LK.

Open Heart. 2018 Oct 8;5(2):e000847. doi: 10.1136/openhrt-2018-000847. eCollection 2018.

7.

Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIV.

Srinivasa S, Fitch KV, Torriani M, Zanni MV, Defilippi C, Christenson R, Maehler P, Looby SE, Lo J, Grinspoon SK.

AIDS. 2019 Feb 1;33(2):229-236. doi: 10.1097/QAD.0000000000002060.

PMID:
30325779
8.

High-sensitivity troponin T in preterm infants with a hemodynamically significant patent ductus arteriosus.

Asrani P, Aly AM, Jiwani AK, Niebuhr BR, Christenson RH, Jain SK.

J Perinatol. 2018 Nov;38(11):1483-1489. doi: 10.1038/s41372-018-0192-x. Epub 2018 Aug 31.

PMID:
30171214
9.

Rationale and design of the Study To Understand Fall Reduction and Vitamin D in You (STURDY): A randomized clinical trial of Vitamin D supplement doses for the prevention of falls in older adults.

Michos ED, Mitchell CM, Miller ER 3rd, Sternberg AL, Juraschek SP, Schrack JA, Szanton SL, Walston JD, Kalyani RR, Plante TB, Christenson RH, Shade D, Tonascia J, Roth DL, Appel LJ; STURDY Collaborative Research Group.

Contemp Clin Trials. 2018 Oct;73:111-122. doi: 10.1016/j.cct.2018.08.004. Epub 2018 Aug 20.

PMID:
30138718
10.

Ultrarapid Rule-out for Acute Myocardial Infarction Using the Generation 5 Cardiac Troponin T Assay: Results From the REACTION-US Study.

Nowak RM, Gandolfo CM, Jacobsen G, Christenson RH, Moyer M, Hudson M, McCord J.

Ann Emerg Med. 2018 Dec;72(6):654-664. doi: 10.1016/j.annemergmed.2018.06.021. Epub 2018 Aug 14.

PMID:
30119942
11.

Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study.

Bazarian JJ, Biberthaler P, Welch RD, Lewis LM, Barzo P, Bogner-Flatz V, Gunnar Brolinson P, Büki A, Chen JY, Christenson RH, Hack D, Huff JS, Johar S, Jordan JD, Leidel BA, Lindner T, Ludington E, Okonkwo DO, Ornato J, Peacock WF, Schmidt K, Tyndall JA, Vossough A, Jagoda AS.

Lancet Neurol. 2018 Sep;17(9):782-789. doi: 10.1016/S1474-4422(18)30231-X. Epub 2018 Jul 24.

PMID:
30054151
12.

Differentiating type 1 and 2 acute myocardial infarctions using the N-terminal pro B-type natriuretic peptide/cardiac troponin T ratio.

Nowak RM, Jacobsen G, Christenson RH, Moyer M, Hudson M, McCord J.

Am J Emerg Med. 2018 Oct;36(10):1849-1854. doi: 10.1016/j.ajem.2018.06.073. Epub 2018 Jul 2.

PMID:
30007549
13.

Corrigendum to 'Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay' [Clin. Biochem. 56 (2018) 4-10].

Christenson RH, Mullins K, Duh SH.

Clin Biochem. 2018 Aug;58:132. doi: 10.1016/j.clinbiochem.2018.06.008. No abstract available.

PMID:
29908760
14.

Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay.

Christenson RH, Mullins K, Duh SH.

Clin Biochem. 2018 Jun;56:4-10. doi: 10.1016/j.clinbiochem.2018.05.004. Epub 2018 May 9. Erratum in: Clin Biochem. 2018 Aug;58:132.

PMID:
29750939
15.

Copeptin to rule out myocardial infarction in Blacks versus Caucasians.

Beri N, Daniels LB, Jaffe A, Mueller C, Anand I, Peacock WF, Hollander JE, DeFilippi C, Schreiber D, McCord J, Limkakeng AT, Wu AHB, Apple FS, Diercks DB, Nagurney JT, Nowak RM, Cannon CM, Clopton P, Neath SX, Christenson RH, Hogan C, Vilke G, Maisel A.

Eur Heart J Acute Cardiovasc Care. 2018 May 1:2048872618772500. doi: 10.1177/2048872618772500. [Epub ahead of print]

PMID:
29737180
16.

N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.

Januzzi JL Jr, Chen-Tournoux AA, Christenson RH, Doros G, Hollander JE, Levy PD, Nagurney JT, Nowak RM, Pang PS, Patel D, Peacock WF, Rivers EJ, Walters EL, Gaggin HK; ICON-RELOADED Investigators.

J Am Coll Cardiol. 2018 Mar 20;71(11):1191-1200. doi: 10.1016/j.jacc.2018.01.021.

17.

"Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).

Peters MN, Seliger SL, Christenson RH, Hong-Zohlman SN, Daniels LB, Lima JAC, de Lemos JA, Neeland IJ, deFilippi CR.

J Am Heart Assoc. 2018 Feb 8;7(4). pii: e006619. doi: 10.1161/JAHA.117.006619.

18.

Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIV.

deFilippi C, Christenson R, Joyce J, Park EA, Wu A, Fitch KV, Looby SE, Lu MT, Hoffmann U, Grinspoon SK, Lo J.

J Acquir Immune Defic Syndr. 2018 May 1;78(1):105-110. doi: 10.1097/QAI.0000000000001644.

PMID:
29419569
19.

Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.

Mindikoglu AL, Opekun AR, Mitch WE, Magder LS, Christenson RH, Dowling TC, Weir MR, Seliger SL, Howell CD, Raufman JP, Rana A, Goss JA, Khaderi SA, Vierling JM.

Dig Dis Sci. 2018 Mar;63(3):665-675. doi: 10.1007/s10620-017-4897-z. Epub 2018 Feb 1.

PMID:
29392554
20.

Novel mediators of statin effects on plaque in HIV: a proteomics approach.

deFilippi C, Lo J, Christenson R, Grundberg I, Stone L, Zanni MV, Lee H, Grinspoon SK.

AIDS. 2018 Apr 24;32(7):867-876. doi: 10.1097/QAD.0000000000001762.

PMID:
29369166
22.

Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis.

Mindikoglu AL, Opekun AR, Putluri N, Devaraj S, Sheikh-Hamad D, Vierling JM, Goss JA, Rana A, Sood GK, Jalal PK, Inker LA, Mohney RP, Tighiouart H, Christenson RH, Dowling TC, Weir MR, Seliger SL, Hutson WR, Howell CD, Raufman JP, Magder LS, Coarfa C.

Transl Res. 2018 May;195:25-47. doi: 10.1016/j.trsl.2017.12.002. Epub 2017 Dec 12.

PMID:
29291380
23.

Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction.

Hachey BJ, Kontos MC, Newby LK, Christenson RH, Peacock WF, Brewer KC, McCord J.

J Am Heart Assoc. 2017 Sep 22;6(9). pii: e005852. doi: 10.1161/JAHA.117.005852.

24.

Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.

Gaggin HK, Chen-Tournoux AA, Christenson RH, Doros G, Hollander JE, Levy PD, Nagurney JT, Nowak RM, Pang PS, Patel D, Peacock WF, Walters EL, Januzzi JL; ICON-RELOADED Investigators.

Am Heart J. 2017 Oct;192:26-37. doi: 10.1016/j.ahj.2017.07.002. Epub 2017 Jul 8.

PMID:
28938961
25.

Quantification of Renal Function and Cardiovascular Mortality in Patients Admitted to the Emergency Department with Suspected Acute Coronary Syndromes.

Bahrmann P, Bertsch T, Giannitsis E, Christ M, Hofner B, Christenson R, Lindahl B, Mueller C.

Clin Lab. 2017 Sep 1;63(9):1457-1466. doi: 10.7754/Clin.Lab.2017.170326.

PMID:
28879725
26.
27.

Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.

Juraschek SP, Miller ER 3rd, Appel LJ, Christenson RH, Sacks FM, Selvin E.

Diabet Med. 2017 Oct;34(10):1407-1413. doi: 10.1111/dme.13391. Epub 2017 Jul 9.

28.

High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: results from the TRAPID-AMI study.

Nowak R, Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, DeFilippi C, McCord J, Body R, Panteghini M, Jernberg T, Plebani M, Verschuren F, French JK, Christenson R, Jacobsen G, Dinkel C, Lindahl B.

Biomarkers. 2017 Dec;22(8):709-714. doi: 10.1080/1354750X.2017.1334154. Epub 2017 Jun 14.

PMID:
28532247
30.

Total Analytic Error for Low Cardiac Troponin Concentrations (≤10 ng/L) by Use of a High-Sensitivity Cardiac Troponin Assay.

Kavsak PA, Jaffe AS, Greene DN, Christenson RH, Apple FS, Wu AHB.

Clin Chem. 2017 May;63(5):1043-1045. doi: 10.1373/clinchem.2017.271361. Epub 2017 Mar 21. No abstract available.

31.

Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.

Loomis SJ, Chen Y, Sacks DB, Christenson ES, Christenson RH, Rebholz CM, Selvin E.

Clin Chem. 2017 May;63(5):980-989. doi: 10.1373/clinchem.2016.264135. Epub 2017 Mar 9.

32.

Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department.

McCord J, Cabrera R, Lindahl B, Giannitsis E, Evans K, Nowak R, Frisoli T, Body R, Christ M, deFilippi CR, Christenson RH, Jacobsen G, Alquezar A, Panteghini M, Melki D, Plebani M, Verschuren F, French J, Bendig G, Weiser S, Mueller C; TRAPID-AMI Investigators.

Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2). pii: e003101. doi: 10.1161/CIRCOUTCOMES.116.003101.

PMID:
28167641
33.

High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).

Seliger SL, Hong SN, Christenson RH, Kronmal R, Daniels LB, Lima JAC, de Lemos JA, Bertoni A, deFilippi CR.

Circulation. 2017 Apr 18;135(16):1494-1505. doi: 10.1161/CIRCULATIONAHA.116.025505. Epub 2017 Feb 3.

34.

Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial.

Juraschek SP, Miller ER 3rd, Selvin E, Carey VJ, Appel LJ, Christenson RH, Sacks FM.

BMJ Open Diabetes Res Care. 2016 Nov 14;4(1):e000276. eCollection 2016.

35.

Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation.

Mueller-Hennessen M, Mueller C, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Ordóñez-Llanos J, Panteghini M, Plebani M, Verschuren F, Melki D, French JK, Christenson RH, Body R, McCord J, Dinkel C, Katus HA, Lindahl B; TRAPID-AMI Investigators.

Clin Chem. 2017 Feb;63(2):542-551. doi: 10.1373/clinchem.2016.258392. Epub 2016 Dec 8.

36.

Cardiorespiratory Fitness and Highly Sensitive Cardiac Troponin Levels in a Preventive Medicine Cohort.

DeFina LF, Willis BL, Radford NB, Christenson RH, deFilippi CR, de Lemos JA.

J Am Heart Assoc. 2016 Nov 28;5(12). pii: e003781.

37.

Necessity of hospitalization and stress testing in low risk chest pain patients.

Beri N, Marston NA, Daniels LB, Nowak RM, Schreiber D, Mueller C, Jaffe A, Diercks DB, Wettersten N, DeFilippi C, Peacock WF, Limkakeng AT, Anand I, McCord J, Hollander JE, Wu AHB, Apple FS, Nagurney JT, Berardi C, Cannon CM, Clopton P, Neath SX, Christenson RH, Hogan C, Vilke G, Maisel A.

Am J Emerg Med. 2017 Feb;35(2):274-280. doi: 10.1016/j.ajem.2016.10.072. Epub 2016 Oct 29.

PMID:
27847253
38.

Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review.

Sandhu PK, Musaad SM, Remaley AT, Buehler SS, Strider S, Derzon JH, Vesper HW, Ranne A, Shaw CS, Christenson RH.

J Appl Lab Med. 2016 Sep 1;1(2):214-229. Epub 2016 Aug 1.

39.

Leveraging the real value of laboratory medicine with the value proposition.

Price CP, John AS, Christenson R, Scharnhorst V, Oellerich M, Jones P, Morris HA.

Clin Chim Acta. 2016 Nov 1;462:183-186. doi: 10.1016/j.cca.2016.09.006. Epub 2016 Sep 17.

PMID:
27649855
40.

Multicenter evaluation of analytical characteristics of the Elecsys® Periostin immunoassay.

Palme S, Christenson RH, Jortani SA, Ostlund RE, Kolm R, Kopal G, Laubender RP.

Clin Biochem. 2017 Feb;50(3):139-144. doi: 10.1016/j.clinbiochem.2016.10.002. Epub 2016 Oct 8.

41.

Defining the Path Forward: Guidance for Laboratory Medicine Guidelines.

Kahn SE, Jones PM, Chin AC, Christenson RH.

EJIFCC. 2015 Aug 24;26(3):158-67. eCollection 2015 Aug.

42.

Impact of moderate physical activity on the longitudinal trajectory of a cardiac specific biomarker of injury: Results from a randomized pilot study of exercise intervention.

deFilippi CR, de Lemos JA, Newman AB, Guralnik JM, Christenson RH, Pahor M, Church T, Espeland M, Krithevsky SB, Stafford R, Seliger SL; LIFE Study Group.

Am Heart J. 2016 Sep;179:151-6. doi: 10.1016/j.ahj.2016.07.001. Epub 2016 Jul 12.

PMID:
27595690
43.

Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population.

Parikh RH, Seliger SL, Christenson R, Gottdiener JS, Psaty BM, deFilippi CR.

J Am Heart Assoc. 2016 Aug 1;5(8). pii: e003188. doi: 10.1161/JAHA.115.003188.

44.

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).

Collinson P, Hammerer-Lercher A, Suvisaari J, Apple FS, Christenson RH, Pulkki K, van Dieijen-Visser MP, Duff CJ, Baum H, Stavljenic-Rukavina A, Aakre KM, Langlois MR, Stankovic S, Laitinen P; Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine.

Clin Chem. 2016 Sep;62(9):1264-71. doi: 10.1373/clinchem.2016.259515. Epub 2016 Jul 26.

45.

Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals.

Fitch KV, DeFilippi C, Christenson R, Srinivasa S, Lee H, Lo J, Lu MT, Wong K, Petrow E, Sanchez L, Looby SE, Hoffmann U, Zanni M, Grinspoon SK.

AIDS. 2016 Sep 10;30(14):2205-14. doi: 10.1097/QAD.0000000000001186.

46.

The Use of Very Low Concentrations of High-sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using a Single Blood Test.

Body R, Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, de Filippi CR, Nowak R, Panteghini M, Jernberg T, Plebani M, Verschuren F, French JK, Christenson R, Weiser S, Bendig G, Dilba P, Lindahl B; TRAPID-AMI Investigators.

Acad Emerg Med. 2016 Sep;23(9):1004-13. doi: 10.1111/acem.13012. Epub 2016 Sep 7.

47.

Galectin-3 and Risk of Heart Failure and Death in Blacks and Whites.

McEvoy JW, Chen Y, Halushka MK, Christenson E, Ballantyne CM, Blumenthal RS, Christenson RH, Selvin E.

J Am Heart Assoc. 2016 May 13;5(5). pii: e003079. doi: 10.1161/JAHA.115.003079.

48.

The standards for reporting diagnostic accuracy studies 2015 update: is there a missing link to the triumvirate?

Wu AH, Christenson RH.

Ann Transl Med. 2016 Feb;4(3):44. doi: 10.3978/j.issn.2305-5839.2015.12.41. No abstract available.

49.

Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T - Sub-analysis from the TRAPID-AMI study.

Mueller-Hennessen M, Lindahl B, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Santalo-Bel M, Panteghini M, Plebani M, Verschuren F, Jernberg T, French JK, Christenson RH, Body R, McCord J, Dilba P, Katus HA, Mueller C; TRAPID-AMI Investigators.

Int J Cardiol. 2016 Apr 15;209:26-33. doi: 10.1016/j.ijcard.2016.01.213. Epub 2016 Feb 3.

PMID:
26878470
50.

Galectin-3 and Soluble ST2 and Kidney Function Decline in Older Adults: The Cardiovascular Health Study (CHS).

Bansal N, Katz R, Seliger S, DeFilippi C, Sarnak MJ, Delaney JA, Christenson R, de Boer IH, Kestenbaum B, Robinson-Cohen C, Ix JH, Shlipak MG.

Am J Kidney Dis. 2016 Jun;67(6):994-6. doi: 10.1053/j.ajkd.2015.12.022. Epub 2016 Jan 29. No abstract available.

PMID:
26830253

Supplemental Content

Loading ...
Support Center